![Peter Thompson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Thompson
Founder at
EDGEWISE THERAPEUTICS, INC.
Net worth: 2 M $ as of 30/09/2026
Profile
Dr. Peter A. Thompson, MD, is an Independent Non-Executive Director at Sionna Therapeutics, Inc., an Independent Director at Aspen Neuroscience, Inc., a Chairman at Edgewise Therapeutics, Inc., an Independent Director at ARS Pharmaceuticals, Inc., an Independent Director at Corvus Pharmaceuticals, Inc., a General Partner at OrbiMed Advisors Private Equity and a Professor at University of Washington.
He is on the Board of Directors at Gennao Bio, Inc., Sionna Therapeutics, Inc., Aspen Neuroscience, Inc., ARS Pharmaceuticals, Inc., Corvus Pharmaceuticals, Inc., Angel Pharmaceuticals Co., Ltd., Cardioxyl Pharmaceuticals LLC, OxOnc Development LP, ReCode Therapeutics, Inc. and Terremoto Biosciences, Inc. Dr. Thompson was previously employed as an Independent Director by Janux Therapeutics, Inc., an Independent Director by Decibel Therapeutics, Inc., an Independent Director by Synthorx, Inc., an Independent Director by Prevail Therapeutics, Inc., an Independent Director by Alpine Immune Sciences, Inc., a Chairman by Silverback Therapeutics, Inc., an Independent Director by PMV Pharmaceuticals, Inc., a Non-Executive Director by Adaptimmune Ltd., an Independent Non-Executive Director by Adaptimmune Therapeutics Plc, an Independent Director by Sierra Oncology, Inc., an Independent Director by Anthera Pharmaceuticals, Inc., a Venture Partner by ATP Capital LP, a Managing Director by Strategicon Partners, a Chairman, President & Chief Executive Officer by Trubion Pharmaceuticals, Inc., a Vice President-Research & Technology by BD Biosciences, Systems & Reagents, Inc., a Vice President-Research & Technology Development by Becton Dickinson Immunocytometry Systems, a Vice President & General Manager-Informatics by Chiron Corp., and a Chairman & Chief Executive Officer by Newyu, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/06/2026 | 210,000 ( 0.25% ) | 2 M $ | 30/09/2026 | |
| 24/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 | |
| 05/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 | |
| 17/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Peter Thompson active positions
| Companies | Position | Start |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Founder | 01/01/2017 |
| CORVUS PHARMACEUTICALS, INC. | Founder | 27/01/2014 |
| ARS PHARMACEUTICALS, INC. | Director/Board Member | 08/11/2022 |
| SIONNA THERAPEUTICS, INC. | Director/Board Member | 01/02/2022 |
OxOnc Development LP
 OxOnc Development LP BiotechnologyHealth Technology Operates as an oncology development company | Director/Board Member | - |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage genetic medicines company that develops therapeutics for genetically defined diseases | Director/Board Member | - |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Director/Board Member | 16/03/2022 |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Founder | - |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases | Director/Board Member | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Former positions of Peter Thompson
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Education of Peter Thompson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
41
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 41 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Response Biomedical Corp.
 Response Biomedical Corp. Medical SpecialtiesHealth Technology Develops acute care diagnostic testing products | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Health Technology |
Anthera Pharmaceuticals, Inc.
 Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
OcuNexus Therapeutics, Inc.
 OcuNexus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, commercializes and manufactures therapeutic products for clinical ophthalmology | Commercial Services |
Cardioxyl Pharmaceuticals LLC
 Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Discovers and develops therapies and technologies for the treatment of cardiovascular diseases | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
Alpine Immune Sciences, Inc. /Old/
 Alpine Immune Sciences, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company which develops cancer immunotherapy systems | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newyu, Inc.
 Newyu, Inc. Information Technology ServicesTechnology Services Provides web-based health information services | Technology Services |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
BD Biosciences, Systems & Reagents, Inc.
 BD Biosciences, Systems & Reagents, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical and diagnostic products | Health Technology |
ATP Capital LP
 ATP Capital LP Real Estate DevelopmentFinance Provides real estate investment and management services | Finance |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Becton Dickinson Immunocytometry Systems
 Becton Dickinson Immunocytometry Systems Medical SpecialtiesHealth Technology Manufactures medical instruments | Health Technology |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious diseases | Health Services |
Strategicon Partners | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
The Warren Alpert Medical School
 The Warren Alpert Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OxOnc Development LP
OxOnc Development LP BiotechnologyHealth Technology Operates as an oncology development company | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that uses synthetic biology to discover and develop protein therapeutics | Health Technology |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage genetic medicines company that develops therapeutics for genetically defined diseases | Health Technology |
ESCAPE Bio, Inc.
 ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Health Technology |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Edgewise Therapeutics, Inc.
 Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Aspen Neuroscience, Inc.
 Aspen Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage regenerative medicine biotechnology company and develops autologous induced-pluripotent stem cell | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases | Health Technology |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
Gennao Bio, Inc.
Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Health Technology |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
ARS Pharmaceuticals, Inc.
 ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Peter Thompson
